Oragene®•Dx
Dna Specimen Collection, Saliva. 510(k) K192920, from DNA Genotek, Inc. (Ottawa, CA). Product code OYJ, class 2.
As of Nov 20, 2026, K192920 is an FDA 510(k) held by DNA Genotek, Inc., substantially equivalent on Jan 14, 2020 after 90 days, with no recalls tied to it in FDA's recall database.
- Review time: 90 days
- Recalls: 0
- Cited as a predicate by: 1 device
Oragene®•Dx is intended for use in the non-invasive collection of saliva samples for in vitro diagnostic testing of human DNA. Saliva may be collected by spitting directly into the Oragene®•Dx container or may be transferred into the Oragene®•Dx container using a sponge. Saliva samples may be collected by a healthcare professional or non-healthcare professional, such as a lay user.
- Oragene-Dx OGD-500; Oragene-Dx OGD-575; Oragene-Dx OXD-525; Oragene-Dx OYD-500K110701 · DNA Genotek, Inc. · Dec 2, 2011
- Oragene DX OGD-500.001K141410 · DNA Genotek, Inc. · Feb 19, 2015
- Oragene DxK152556 · DNA Genotek, Inc. · May 26, 2016
- ORAcollect®•DxK212745 · DNA Genotek, Inc. · Oct 27, 2022
- ORAcollect®•DxK212745 · DNA Genotek, Inc. · Oct 27, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Oct 16, 2019
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1675
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files